CACCC boxes are among the critical sequences present in regulatory elements of genes expressed in erythroid cells, as well as in selected other cell types. While an erythroid cell-specific CACCC-box-binding protein, EKLF, has been shown to be required in vivo for proper expression of the adult ␤-globin gene, it is dispensable for the regulation of several other globin and nonglobin erythroid cell-expressed genes. In the work described here, we searched for additional CACCC-box transcription factors that might be active in murine erythroid cells. We identified a major gel shift activity (termed BKLF), present in yolk sac and fetal liver erythroid cells, that could be distinguished from EKLF by specific antisera. Through relaxed-stringency hybridization, we obtained the cDNA encoding BKLF, a highly basic, novel zinc finger protein that is related to EKLF and other Krüppel-like members in its DNA-binding domain but unrelated elsewhere. BKLF, which is widely but not ubiquitously expressed in cell lines, is highly expressed in the midbrain region of embryonic mice and appears to correspond to the gel shift activity TEF-2, a transcriptional activator implicated in regulation of the simian virus 40 enhancer and other CACCC-box-containing regulatory elements. Because BKLF binds with high affinity and preferentially over Sp1 to many CACCC sequences of erythroid cellexpressed genes, it is likely to participate in the control of many genes whose expression appears independent of the action of EKLF.
Proteins that recognize CACCC sequences have been implicated in the regulation of diverse genes in both erythroid and nonerythroid cells. These include erythroid cell-expressed genes, such as the ␤, ␥, and globins (25) , porphobilinogen deaminase (11, 21) , pyruvate kinase (18, 19) , carbonic anhydrase (8) , and GATA-1 (36) , as well as genes expressed in other tissues, such as those encoding the T-cell receptor (37) , tyrosine aminotransferase (2) , and tryptophan oxygenase (5) . CACCC boxes are also critical components of viral regulatory elements, such as the simian virus 40 (SV40) enhancer (39) . In addition, CACCC boxes are often found in close association with other motifs. For example, CACCC boxes in erythroid cell regulatory regions are frequently located ϳ20 to 30 bp from GATA motifs (28) . Accordingly, the erythroid transcription factor GATA-1 physically interacts and synergistically activates transcription with CACCC-box-binding proteins of the Krüp-pel family of zinc finger proteins in transfected cells (10, 20) . In other cell types, proteins bound to CACCC motifs cooperate with the glucocorticoid receptor (31, 34) .
Recently, cDNA encoding a Krüppel-related polypeptide, designated EKLF, was characterized and demonstrated to represent a CACCC-binding protein (22) . EKLF expression is highly restricted to erythroid cells of both yolk sac and fetal liver origins (7, 22, 27) . In pursuit of its in vivo role, the EKLF gene was disrupted in mouse embryonic stem cells and EKLF Ϫ/Ϫ embryos were generated (24, 27) . These embryos reveal a profound reduction in ␤-globin expression. Remarkably, other genes whose promoters contain functional CAC CC-box elements, such as the GATA-1, porphobilinogen deaminase, erythroid pyruvate kinase, carbonic anhydrase and ␤h1 globin genes, are expressed at normal (or near-normal) levels in EKLF Ϫ/Ϫ embryos. These findings provide clear evidence for the existence of additional CACCC-binding proteins that are likely to control diverse target genes in erythroid cells.
In an effort to characterize these other CACCC factors, we performed gel shift analysis of murine erythroid cell nuclear extracts and identified a prominent activity for further study. This activity is of particular interest in that it appears to be an abundant CACCC-box-binding protein in erythroid cells and binds to CACCC sequences more avidly than to GC-rich sites, those commonly recognized by Sp1. By cDNA cloning, we have shown that this protein, designated BKLF/TEF-2, is another member of the Krüppel family of transcription factors, distinguished by its basic charge (hence, BKLF). Its DNA-binding specificity resembles that of EKLF but is distinct. We show that BKLF binds with high affinity to numerous CACCC motifs found in erythroid cis-regulatory elements, including those of the ␤-globin, GATA-1, porphobilinogen deaminase, pyruvate kinase, and carbonic anhydrase gene promoters and globin locus control cores. We show that both BKLF and EKLF proteins are expressed in murine embryonic and definitive hematopoietic tissues; however, BKLF appears to be more abundant. Unlike EKLF, however, BKLF is not confined to erythroid cells but is present in a number of cell types. In the developing mouse embryo, expression is particularly striking in the midbrain region. Our results also suggest that BKLF corresponds to TEF-2/GT-IC, an activity first described in the context of the SV40 enhancer. Taken together, our findings P]dATP, dCTP, and dGTP and bromodeoxyuridine, by following standard protocols (30) . This probe was then used in gel shift experiments as described above. The gel was then exposed to UV light in a GS Genelinker UV cabinet (Bio-Rad) for 8 min. The bands corresponding to Sp1, BKLF, and COS-expressed EKLF were identified after brief autoradiography at 4ЊC and excised. They were then homogenized, boiled in sodium dodecyl sulfate (SDS), and subjected to electrophoresis on an SDS-polyacrylamide gel (30) . The gel was then dried and subjected to autoradiography.
Library screening. A mouse erythroleukemia (MEL) cell cDNA library contained in the bacteriophage vector gt11 was screened with a mixed probe containing the EKLF and Sp1 zinc finger domains. These regions were amplified from EKLF and Sp1 cDNAs by using the primer pairs GCTGAATTCACCAT GGCGCCGCCCAAACGCAGC plus TCCGGATCCAGAGGTGACGCTTCA TGTG and GCCAAGCTTGGCAAAAAGAAACAGCACATTTG plus GATT TGCGGCCGCTTTGACAGATGATCGCTCCTCAT, respectively. In all, approximately 4 ϫ 10 5 plaques were screened. Filters were hybridized for 16 h at 56ЊC in 6ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-2ϫ Denhardt's solution-200 g of sonicated salmon sperm DNA per ml-0.1% SDS, washed twice for 30 min each in 2ϫ SSC at 40ЊC, and subjected to autoradiography. The filters were subsequently washed again at high stringency (65ЊC in 0.2ϫ SSC) and reexposed. Twenty-two plaques which hybridized at low but not at high stringency were selected and isolated. The inserts from these phages were then cloned into the EcoRI site of pUC18 and sequenced.
Purification of BKLF from MEL cells. MEL cell nuclear extract was prepared (6), dialyzed for 60 min against 1 liter of 20 mM HEPES (pH 7.8)-50 mM KCl-5 mM MgCl 2 -0.2 mM EDTA-20% glycerol-10 M ZnCl 2 -1 mM dithiothreitol at 4ЊC, clarified by brief centrifugation, and then passed over a monoS fast protein liquid chromatography column (Pharmacia) equilibrated in 20 mM HEPES (pH 7.8)-50 mM NaCl-5 mM MgCl 2 -0.2 mM EDTA-20% glycerol-10 M ZnCl 2 -1 mM dithiothreitol-0.5 mM phenylmethylsulfonyl fluoride-5 g of pepstatin, leupeptin, and aprotinin per ml. Bound proteins were eluted with a 60-ml gradient of sodium chloride (100 mM to 1 M). Fractions (1 ml) were collected and assayed for BKLF activity by gel shift analysis. Fractions containing BKLF activity, free of Sp1, CAC-C, or EKLF as detected by the gel shift assay, were pooled and dialyzed.
Schneider cell culture and transfection. Drosophila melanogaster SL2 cell transfections were carried out as previously described (20) . Cells were transfected with 2 g of the previously described reporter plasmid, which contains one BKLF-binding site upstream of a TATA box and the bacterial chloramphenicol acetyltransferase gene (20) , and 5 g of transactivator plasmid, either pPac alone (17) , pPac/Sp1 (26) , pPac/EKLF (20) , or pPac/BKLF. pPac/BKLF was constructed by cloning nucleotides 7 to 1179 of BKLF (i.e., a fragment containing the entire open reading frame and a small amount of the 5Ј untranslated region) between the BamHI and XhoI sites of pPac/Sp1.
In situ analysis of developing mouse embryos. Whole-mount in situ hybridizations were performed essentially as described by Wilkinson (38) . Nucleotides 1 to 848 of BKLF were subcloned between the BamHI and EcoRI sites of Bluescript II KS (Stratagene) to allow for generation of antisense riboprobe by using T3 polymerase with digoxigenin-UTP (Boehringer Mannheim). A sense riboprobe was used as a negative control for the whole-mount analysis.
Western blotting. Cultured cells, fetal liver samples, and fetal head samples were homogenized in SDS-polyacrylamide gel electrophoresis (PAGE) loading dye and immediately frozen at Ϫ80ЊC. Equal amounts of protein were resolved by SDS-PAGE (10% polyacrylamide), electrotransferred to nitrocellulose, and subjected to Western blotting (immunoblotting) (30) . BKLF was detected by chemiluminescence with anti-rabbit horseradish peroxidase and a commercial kit (Amersham) following incubation for 1 h at room temperature with a 1:1,000 dilution of the polyclonal rabbit anti-GST-BKLF antiserum. GATA-1 protein was detected similarly with a monoclonal rat anti-mouse GATA-1 (Santa Cruz Biotech).
Nucleotide sequence accession number. The GenBank accession number of the BKLF sequence is U36340.
RESULTS

BKLF, a CACCC-binding activity distinguishable from EKLF.
Nuclear extract of MEL cells contains several activities which form a complex on the ␤-globin CACCC sequence (14) (Fig. 1,  lane 3) . The most slowly migrating complex includes Sp1 and Sp1-related proteins (reference 14 and unpublished data). The identity of the remaining complexes had to be established. To determine which complex contains EKLF under our gel shift conditions, we expressed recombinant EKLF in COS cells (lane 1) and used an antibody to EKLF to supershift the relevant complex (lane 2). With MEL cell extract, a minor complex of similar mobility is seen (lane 3) and is also abolished by antibody treatment (lane 4). A major complex present in MEL cells, designated BKLF (see below), is unaffected by treatment with anti-EKLF antibody. These findings suggest that the EKLF and BKLF complexes contain distinct proteins, as judged by immunologic criteria. This conclusion was unanticipated, as preliminary data suggested that the BKLF complex might correspond to that produced by EKLF. First, EKLF binds avidly in vitro to the ␤-globin CACCC site and is required for its in vivo expression. Likewise, the BKLF complex is formed efficiently on the same site. Second, UV cross-linking experiments with recombinant EKLF and partially purified MEL cell BKLF protein showed that the two proteins migrate similarly in an SDS-polyacrylamide gel (Fig. 2) . Thus, while the gel shift findings presented in Fig. 1 suggest that the EKLF and BKLF complexes contain distinct proteins, they do not exclude the possibility that BKLF is a variant or heterodimeric form of EKLF in which epitopes detected by antibody directed to EKLF are either missing or masked. Finally, BKLF gel shift activity (previously suggested to be CACD [14] ) is selectively reduced in nuclear extracts of fetal liver erythroid cells of EKLF Ϫ/Ϫ embryos (27; also see below). Isolation of BKLF cDNA. To resolve the above ambiguities, we isolated cDNA encoding the protein present in the BKLF gel shift complex. Given that EKLF, Sp1, and the novel BKLF activities recognize similar DNA sequences, we speculated that the DNA-binding domain of BKLF might also be closely related to these Krüppel family members. We screened a MEL cDNA library under relaxed stringency with a mixed probe containing sequences encompassing the zinc finger regions of EKLF and Sp1. Twenty-two clones which hybridized to the probe at low but not high stringency were isolated and sequenced. Of these, eight encoded Sp3 (five clones) and Sp4 (three clones). Three clones represented a novel transcript and were chosen for further analysis. The largest (designated BKLFclone 1) contained an open reading frame of 344 amino acids, encoding a potential polypeptide of 38.5 kDa (Fig. 3a) .
Inspection of its deduced polypeptide sequence reveals that BKLF is a member of the Krüppel family and most highly related in its zinc finger region to BTEB2 (33) (Fig. 3b) . In this region, BKLF is also highly related to EKLF, Sp1, and BTEB1 (16) . Outside the finger region, BKLF is unrelated to these proteins; however, like EKLF, it is proline rich. Although its calculated molecular weight is similar to that of EKLF, the predicted BKLF polypeptide is considerably more basic, with a calculated isoelectric point of 10.2 compared with 7.0 for EKLF. This finding presumably accounts for the slower mobility of the BKLF complex in native gels yet the equivalent migration of EKLF and BKLF polypeptides in the presence of SDS (Fig. 2) .
Proteolytic clipping establishes that BKLF-clone 1 encodes BKLF. Nuclear extract of COS cells expressing recombinant protein encoded by the BKLF clone was used in gel shift assays. A complex was generated on the ␤-globin probe that comigrates with partially purified BKLF of MEL cells and with BKLF present in MEL cell nuclear extract ( Fig. 4 and 5a ). To verify that the protein encoded by BKLF-clone 1 is BKLF, proteolytic clipping experiments were performed. Samples of nuclear extract of COS cells expressing the cDNA and partially purified MEL cell BKLF were digested with increasing amounts of chymotrypsin, trypsin, or protease K immediately prior to gel retardation analysis. The profiles generated by digestion of partially purified MEL BKLF and the expressed candidate clone were indistinguishable (Fig. 4) . The comigration of COSexpressed BKLF-clone 1 and BKLF from MEL cells (Fig. 4 and 5a and unpublished results) strongly suggests that the BKLF clone-1 cDNA represents a full-length clone of BKLF. The authenticity of this clone is further supported by antibodysupershifting experiments described below.
BKLF is the major CACCC factor expressed in yolk sac and fetal liver of the developing mouse.
To authenticate the cDNA and analyze the expression pattern of BKLF protein in various cell types, we raised antibody directed to the amino-terminal 268 amino acids of the predicted polypeptide, a region which shows no significant homology to other zinc finger proteins. As shown in Fig. 5a , the antibody supershifted the recombinant BKLF complex in COS cells (lanes 1 and 2), as well as the BKLF complex in MEL cells (lanes 7 and 8). These findings confirm proteolytic clipping experiments and demonstrate that the BKLF protein is solely responsible for the BKLF gel shift observed in MEL cells. FIG. 2. BKLF and EKLF migrate similarly under denaturing conditions. Sp1, BKLF, and EKLF protein complexes were isolated and exposed to UV light to cross-link the protein and probe. Samples were then electrophoresed through an SDS-polyacrylamide gel and exposed to film. The migration reflects the total molecular mass of the cross-linked complex (protein plus probe).
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We also assessed BKLF in nuclear extracts of purified yolk sac and fetal liver erythroid cells (lanes 3 to 6). BKLF is present at similar abundances in yolk sac and fetal liver erythroid cells (lanes 3 to 6). It should be noted that BKLF antibody fails to inhibit Sp1-or EKLF-containing complexes. Moreover, EKLF antibody specifically removes the EKLF gel shift in the same erythroid-cell extracts (Fig. 5b) . These results indicate that BKLF is the major component of the gel shift band designated BKLF in MEL cells and also in developing murine erythroid tissues (yolk sac and fetal liver).
BKLF transcripts are highly expressed in the developing midbrain region. In cell lines, BKLF is widely but not ubiquitously expressed (see below). To gain further insights, wholemount in situ hybridization analysis of BKLF expression was performed with murine embryos at 7.5 to 10.5 days postcoitum (p.c.). Strong staining was initially detected at 8.5 days p.c. as a broad band in the midbrain and anterior hindbrain (Fig. 6A) and also in the ventral forebrain (Fig. 6B) . At 9 days pc, diffuse staining was detected in the ventral anterior half of the embryo with restricted signals at a circle at the midbrain-hindbrain junction as well as the ventral midbrain, diencephalon, and forebrain (Fig. 6C) . At 10.5 days p.c., expression was more widespread (Fig. 6D) , with less intense staining also detected in the developing limb buds. Although BKLF RNA (data not shown) and protein are present in the yolk sac, transcripts are not readily detected by in situ analysis, presumably because of the lower sensitivity of the method.
BKLF corresponds to TEF-2/GT-IC. The BKLF gel shift resembles that previously termed TEF-2 (or GT-IC) (39) . TEF-2 was originally described as an activity that binds to the To determine the relationship between BKLF and TEF-2/ GT-IC, we used a probe encompassing the TEF-2-binding site in the SV40 enhancer and performed gel shift experiments comparing HeLa and MEL cell extracts. As shown in Fig. 7,   FIG. 4 . Proteolytic clipping of recombinant BKLF expressed in transfected COS cells and partially purified MEL BKLF. A gel shift experiment was carried out as in Fig. 1 , except that the samples were first exposed to a brief treatment by the indicated proteases. The samples were electrophoresed in parallel. For this figure, a longer autoradiographic exposure of the MEL samples has been used to facilitate comparisons.
FIG. 5. BKLF and EKLF gel shift complexes in yolk sac and fetal liver samples. (a) BKLF is a major CACCC-box-binding activity in murine erythroid tissues. Gel shift assays were performed with the ␤-globin CACCC-site probe and nuclear extracts from the indicated sources. The complexes are designated as in Fig. 1 . Preimmune serum or anti-BKLF antibody was added to lanes 1, 3, 5, and 7 and lanes 2, 4, 6, and 8, respectively. In lanes 1 and 2, 2 g (rather than 10 g) of nuclear extract was used; therefore, the endogenous Sp1 complex in COS cells is barely visible. (b) Detection of the EKLF complex in murine erythroid tissues. The experiment was performed as in panel a. Preimmune serum or anti-EKLF antibody was added to lanes 1, 3, 5, and 7 and lanes 2, 4, 6, and 8, respectively. The EKLF complexes in the fetal liver and MEL cell samples (lanes 5 and 7) were barely detectable in this experiment but were confirmed in other preparations.
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In certain cell lines, non-BKLF/TEF-2 proteins generate a TEF-2-like gel shift.
A gel shift activity resembling BKLF/ TEF-2 has been observed in a variety of cell lines. Northern blotting shows that BKLF transcripts are expressed widely in the adult (Fig. 8a) . On this basis, it might be presumed that TEF-2 is a ubiquitous DNA-binding protein. To determine if this is the case, we performed additional supershift experiments. As shown in Fig. 8b , all cell lines tested exhibited a BKLF/TEF-2-like gel shift activity but BKLF was a major component of this complex only in MEL, K562, HeLa, and NIH 3T3 cells. In COS, Jurkat, mouse embryonic stem (ES), and 293 cells, BKLF constituted a minor proportion of or was undetectable in the gel shift complex. Thus, BKLF/TEF-2 is not strictly ubiquitous in its distribution.
BKLF is selectively reduced but present in EKLF ؊/؊ fetal liver erythroid cells. We previously reported that a major gel shift activity (then referred to as CACD [14] ) was markedly A) . Later, specific expression also extended ventrally in the central nervous system, with strong staining in the ventral forebrain (open arrow) as well as the midbrain and anterior hindbrain (solid arrow). At 9 days p.c. prominent, diffuse expression was evident in the ventral anterior half of the embryo, but in the midbrain, staining was restricted to a circle at the midbrain-hindbrain junction (arrow in panel C). At 10.5 days p.c., expression was more widespread but strong staining was still evident in the central nervous system, particularly at the midbrain-hindbrain junction (arrow), as well as the ventral midbrain, diencephalon, and forebrain. Less intense staining was also detected in the developing limb buds (arrowhead in panel D). ys, yolk sac. (27) . Although the simplest interpretation might be that this reflects the level of EKLF itself, our current data distinguishing BKLF and EKLF show this not to be the case. As shown in Fig. 9a , the BKLF gel shift is reduced but not absent in EKLF Ϫ/Ϫ erythroid cells, as would be anticipated if this complex contained EKLF. In addition, antibody supershift experiments establish that the complex contains BKLF. The reduced level of BKLF gel shift activity is due to less protein (approximately 5-to 10-fold), as shown by Western blot analysis of fresh fetal liver samples (Fig. 9b) . As a control for the erythroid cell contribution to these fetal liver samples, the Western blot was reprobed with GATA-1 antiserum, which demonstrated equivalent loading of extracts. In contrast to these findings, BKLF protein was equally abundant in head regions of EKLF Ϫ/Ϫ and EKLF ϩ/Ϫ embryos (Fig. 9b) . Also, as shown in Fig. 9b , BKLF protein is more abundant in mature than immature MEL cells. Therefore, BKLF protein is selectively reduced but not absent in erythroid cells lacking EKLF. This effect is not at the transcriptional level, because BKLF transcripts appear to be equally abundant in EKLF Ϫ/Ϫ and control samples (not shown). These findings are discussed below.
BKLF functions as a transcriptional activator. We also investigated whether BKLF, like its related proteins EKLF and Sp1, can serve as a transcriptional activator. Perhaps because of the presence of endogenous CACCC-box-binding proteins, it has proved challenging to devise suitable transactivation assays for these proteins in mammalian cells. In this instance, transactivation experiments with Drosophila cells, which do not contain endogenous Sp1, have been helpful. A chloramphenicol acetyltransferase reporter gene, under the control of the ␤-globin TATA box and a single BKLF-binding site, was transfected into Drosophila Schneider cells in the absence or presence of an expression vector encoding BKLF. As shown for a representative experiment in Fig. 10 , BKLF activated transcription ϳ5-to 10-fold. Under the same conditions, EKLF and Sp1 also activated transcription from the reporter plasmid, albeit at somewhat higher levels. We conclude that BKLF is able to function as a transcriptional activator.
BKLF and EKLF both bind strongly to the ␤-globin CACCC motif. Although all CACCC-box-binding proteins so far described recognize both CACCC and CGCCC sequences, they display clear preferences. EKLF, for instance, binds more readily to the ␤-globin than the ␥-globin CACCC box (CCA CAC CCT versus CTC CAC CCA) and prefers CACCC to CG-rich sequences (references 7 and 9 and unpublished results). Conversely, Sp1 binds preferentially to GCC CGC CCC compared with the ␤-globin CACCC box (references 14 and 39 and unpublished results). We performed competition analysis to determine the preference of BKLF. MEL cell nuclear ex- FIG. 7 . BKLF corresponds to the HeLa gel shift activity designated TEF-2 (or GT-IC). In this gel shift experiment, a double-stranded oligonucleotide probe containing the SV40 enhancer CACCC-box sequences was used. Preimmune serum or anti-BKLF antibody was added to lanes 1 and 3 and lanes 2 and 4, respectively. VOL. 16, 1996 CHARACTERIZATION OF BKLF/TEF-2 cDNA 1701 tract was used so that BKLF binding could be directly compared with the binding of Sp1 family proteins. As shown in Fig.  11a , the ␤-globin CACCC box competes most effectively for the binding of BKLF whereas the ␥-globin and CG-rich sequences compete more effectively for Sp1-like binding. With respect to these binding properties, BKLF appears to resemble EKLF more than it resembles the Sp1 family of proteins, a result which is consistent with its high homology to EKLF in its zinc finger region. BKLF binds avidly to CACCC motifs found in many erythroid cell genes. A combination of functional assays and in vivo and in vitro analyses have identified CACCC boxes in the cis-regulatory regions of numerous erythroid cell genes. As a first step to considering which of these might be targets of BKLF, we carried out gel shift experiments to determine which of these bind strongly to BKLF and therefore might be candidate target genes in vivo. Initially, BKLF binding was assessed directly by using each site as a probe (data not shown), and then the ability of each site to compete for the binding of BKLF to the ␤-globin CACCC box was monitored (Fig. 11b) . In all, 13 different CACCC sites were found to bind BKLF (summarized in Table 1 ). Of these, the CACCC sequences present in the ␤-and ␤h1-globin, rat erythroid pyruvate kinase, erythroid carbonic anhydrase I promoters, the proximal site in the GATA-1 promoter, the distal site in the PBGD promoter, and two sites in the human locus control region (one in HS2 and one in HS3) bound strongly.
DISCUSSION
A prerequisite for understanding the combinatorial mechanisms that govern patterns of gene expression is characterization of the relevant component proteins. CACCC-box-binding proteins have been implicated in the regulation of numerous erythroid cell genes (4, 12, 15, 18, 19) . Their identification and study have been hampered by the multiplicity of factors that recognize a single motif (14, 22) . The observation that EKLF Ϫ/Ϫ mice have impaired ␤-globin production but appear to express other genes normally suggests that additional CAC CC-binding proteins play a role in transcriptional control in erythroid cells and/or compensate for the loss of EKLF. Here, we have described the cloning of a cDNA encoding a novel CACCC-box-binding protein (BKLF), which appears to be the predominant CACCC factor present in nuclear extracts of erythroid cells. We have shown that BKLF is a member of the Krüppel family of transcription factors and is highly related in its DNA-binding domain to EKLF (and its relatives BTEB2 and BTEB1) but unrelated in other domains.
Our data suggest that BKLF is equivalent to the previously described activity TEF-2/GT-IC. We also show that BKLF is a major CACCC-binding species in murine yolk sac and fetal liver erythroid cell nuclear extracts. As detected by gel shift assay, it appears considerably more abundant than EKLF in these tissues. Others have described multiple CACCC-binding activities in MEL cell extracts (14) . Initially, we presumed that the complex designated BKLF corresponded to CACD of Hartzog and Myers by comparison of our gel shift patterns with their published findings (14, 27) . Unless BKLF and EKLF complexes were not resolved under their gel shift conditions, this conclusion is untenable, since purified protein thought to represent CACD reacts with EKLF antibody (2a) . Because of the difficulties inherent in comparing gel shift patterns obtained with different cell lines and in different laboratories, we cannot easily relate our findings to the gel shift complexes previously designated CACC and CACD (14) . It seems most prudent to discuss only those complexes for which molecular reagents (cDNA and antibodies) are characterized.
As with other sets of transcription factors that recognize similar or identical sequences, it is difficult to ascribe specific functions to particular members of the CACCC-binding family other than EKLF. In the instance of EKLF a specific role in ␤-globin gene transcription is suggested by in vitro transactivation studies (3) and more conclusively established by the EKLF Ϫ/Ϫ phenotype (24, 27) . The original studies of the SV40 enhancer revealed a correlation between the binding of TEF-2/GT-IC, presumed here to be BKLF, and enhancer activity (23) , consistent with our observation that BKLF can function as a transcriptional activator. There remains the outstanding question of the nature of the cellular genes regulated by BKLF in vivo. Given the finding that the promoters of diverse genes depend on CACCC sites for their activity, many will be candidate targets for BKLF. In surveying binding sites, we have identified a subset of sites that are preferred by BKLF. Some are of particular interest. The favorable CACCC site in the ␤h1-globin promoter suggests that BKLF, rather than EKLF, may participate in its regulation in vivo, a possibility consistent with its normal expression in EKLF Ϫ/Ϫ embryos. A high-affin- a Binding sites were assigned as strong or weak on visual inspection of the competition data shown in Fig. 11b and the relative binding of individual probes to BKLF in gel shift assays (not shown).
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on October 26, 2015 by University of Queensland Library http://mcb.asm.org/ ity site in the promoter of the GATA-1 gene suggests a potential role for BKLF in activating or maintaining expression of this central erythroid cell transcription factor. Moreover, the presence of high-affinity sites in evolutionarily conserved sequences of the ␤-LCR HS2 and HS3 cores (13, 29, 35) raises the possibility that BKLF functions at these upstream, dominant regulatory elements. Nonetheless, it is apparent that other proteins, such as Sp1 and other, as yet uncharacterized activities (e.g., CACC [14] ), may be the true effector proteins at some of these sites in vivo. Ongoing targeted disruption of the BKLF gene in ES cells should assist in pinpointing relevant in vivo targets, particularly in concert with creation of doubleknockout BKLF Ϫ/Ϫ /EKLF Ϫ/Ϫ embryos. The decreased level of BKLF protein but not mRNA in EKLF Ϫ/Ϫ erythroid tissue (Fig. 9) is an unexpected secondary consequence of EKLF loss. We suspect that this arises from failure of complete maturation of EKLF Ϫ/Ϫ erythroid cells. Consistent with this interpretation is the accumulation of BKLF protein during MEL cell differentiation (Fig. 9b) . These findings underscore complex cellular effects that confound analysis of knockouts that ultimately interfere with production of end-stage, differentiated cells.
Although we characterized BKLF in the context of CACCC factors in erythroid cells, it seems probable that it functions in a variety of tissues. Northern blotting shows that BKLF transcripts are expressed widely in the adult (Fig. 8a ). In the developing mouse embryo, high-level expression is more restricted, principally to the midbrain and anterior hindbrain region. Thus, a role for BKLF in central nervous system development will have to be considered. Our finding that a BKLF/TEF-2-like gel shift complex in some cells does not contain BKLF raises an additional note of caution in assigning CACCC-box factors from gel shift experiments without confirmatory antibody inhibition studies.
Like GATA motifs and NF-E2 sites, CACCC boxes have long been recognized as critical sequences in the regulatory regions of erythroid cell-expressed genes (25) . With the cloning of cDNA for EKLF, the first unequivocal regulator of erythroid CACCC-dependent genes emerged (22) . As shown by the phenotype of EKLF Ϫ/Ϫ embryos, erythroid cells have a circumscribed requirement for EKLF (24, 27) . The findings reported here suggest that BKLF/TEF-2, on the other hand, is a candidate to fulfill broader functions in this lineage and selected other cell types.
